Certain mold infections, particularly invasive aspergillosis, can promote blood clot formation through direct damage to blood vessels, activation of platelets, and chronic inflammation. The relationship is not as simple as “mold exposure equals clots,” though. The type of exposure matters enormously: an active fungal infection growing inside your body operates through completely different mechanisms than inhaling mold spores in a damp basement. And in a twist that surprises many people, some mold-produced toxins actually push clotting in the opposite direction, impairing your blood’s ability to clot rather than making it clot too much.
How Invasive Mold Infections Trigger Clots
The strongest evidence linking mold to blood clots comes from invasive fungal infections, where mold literally grows into your tissue and blood vessels. Aspergillus fumigatus, one of the most common disease-causing molds, is particularly aggressive in people with weakened immune systems. In transplant recipients and patients on immunosuppressive drugs, the fungus can penetrate deep into tissue, pushing hyphae (thread-like fungal filaments) through the walls of blood vessels in a process called angioinvasion. When fungal filaments breach a vessel wall, they damage the inner lining and trigger the body’s clotting machinery right at the site of invasion.
Animal studies show how dramatically immune status changes the picture. In a transplant model, syngeneic grafts (where the immune system remains functional) showed fungal growth that stayed mostly on the surface, analogous to simple colonization. But in allogeneic transplants, where immune rejection weakened the tissue, Aspergillus fumigatus invaded aggressively all the way down to the cartilage layer, penetrating far beyond the surface lining.1PLOS ONE. Aspergillus fumigatus Invasion Increases with Progressive Airway Ischemia The clinical consequences of this kind of invasion can be devastating. Case reports describe Aspergillus forming dense fungal masses inside major blood vessels. One documented case involved a lethal thrombosis of the iliac artery after liver transplantation, where examination revealed a solid Aspergillus fumigatus conglomerate blocking the vessel.2PubMed Central. Lethal thrombosis of the iliac artery caused by Aspergillus fumigatus after liver transplantation: case report and review of the literature
Beyond directly blocking vessels, angioinvasive fungi can weaken arterial walls and cause other vascular complications. Both Aspergillus and certain other invasive molds exhibit behavior that damages vessel integrity, sometimes leading to pseudoaneurysms in the pulmonary arteries, which can rupture with fatal results.3The Egyptian Journal of Bronchology. Delayed fatal pulmonary artery pseudoaneurysm following dual invasive pulmonary fungal infection- a case report These are extreme scenarios, and they overwhelmingly affect people whose immune systems are severely compromised. For a healthy person, the body’s defenses typically contain Aspergillus spores long before they reach this stage.
Why Fungi Activate Your Platelets
Even before a full-blown invasive infection develops, fungi interact with platelets in ways that promote clotting. Platelets are not just passive players waiting around for a wound. They actively respond to fungal invaders as part of the immune system’s early defense, and that response can tip the balance toward unwanted clot formation.
Aspergillus fumigatus is a potent trigger for platelet activation. When platelets encounter the fungus, they ramp up surface markers associated with clotting and inflammation and release a cocktail of signaling molecules. Hyphae, the mature branching form of the fungus, are especially strong activators compared to conidia (the dormant spore form). The activated platelets don’t just clot; they also boost inflammatory signaling in nearby immune cells, creating a feedback loop that amplifies both inflammation and clotting at the infection site.4PubMed Central. Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
What makes this especially interesting is that the fungus does not need to physically touch platelets to activate them. Aspergillus fumigatus and Aspergillus flavus secrete a sugar-based molecule called galactosaminogalactan (GAG) that can stimulate platelets at a distance. Researchers found that culture supernatants from these species were potent platelet stimulators in a dose- and time-dependent manner, and the effect depended specifically on GAG production. Mutant strains of A. fumigatus that lacked GAG secretion did not affect platelet activity, confirming it as the active ingredient. Other mold genera, like the mucormycetes, did not trigger this response.5Microbes and Infection. Galactosaminogalactan secreted from Aspergillus fumigatus and Aspergillus flavus induces platelet activation This means invading Aspergillus can promote clotting not only where hyphae physically contact vessel walls, but in surrounding tissue reached by secreted fungal products.
At the same time, not all fungal components push platelets in the same direction. Short fragments of beta-glucan, a molecule found in many fungal cell walls, were shown to actually dampen platelet activation. At low concentrations, these fragments reduced the release of key clotting mediators and decreased platelet aggregation and the interaction between activated platelets and other immune cells.6PubMed Central. Short fungal fractions of β-1,3 glucans affect platelet activation So even within the same organism, different molecular components can have opposing effects on clotting, which partly explains why the clinical picture is so variable.
Chronic Infection, Chronic Inflammation, and Clot Risk
Invasive aspergillosis is not the only scenario where mold and clotting intersect. Chronic forms of pulmonary aspergillosis, where the fungus persists in the lungs over months or years without the dramatic tissue invasion seen in immunocompromised patients, also appear to shift the body toward a clot-prone state. Patients with chronic necrotizing pulmonary aspergillosis show elevated blood levels of several inflammation markers and, critically, elevated levels of molecules directly involved in clotting. These include von Willebrand factor (which helps platelets stick to damaged vessels), tissue factor (which kicks off the clotting cascade), and PAI-1 (which prevents the body from breaking down clots once they form).7PubMed Central. Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis
This matters because it suggests that even without direct vascular invasion, the chronic inflammatory state created by an ongoing fungal infection can tilt the body’s clotting balance. Inflammation and clotting are deeply intertwined: inflammatory signals activate the clotting system, and clotting proteins amplify inflammation in return. A systematic review examining chronic pulmonary aspergillosis and venous blood clots proposed several mechanisms by which they coexist, including endothelial damage from fungal invasion, chronic inflammation, and simple immobilization from severe lung disease keeping patients bedridden.8PubMed Central. Chronic pulmonary aspergillosis and pulmonary embolism/venous thromboembolism: a case series and systematic review of the literature
Aspergillus also produces secondary metabolites, including gliotoxin, that directly damage blood vessel lining cells. In laboratory studies, Aspergillus culture filtrates profoundly inhibited the ability of endothelial cells to migrate, differentiate, and form new capillary tubes.9Blood. Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites Damaged endothelium is one of the classic triggers for clot formation, so this represents yet another pathway by which the fungus creates conditions favorable to thrombosis.
Mycotoxins and Clotting Disruption in the Other Direction
Here is where the story takes an unexpected turn. When people worry about mold and blood clots, they are often thinking about the kind of mold growing in a water-damaged building rather than an active infection. The chemicals these molds produce, called mycotoxins, do affect clotting, but the dominant effect in the best-studied toxins is to impair clotting rather than promote it.
The most detailed work comes from animal studies on aflatoxin and ochratoxin A, two mycotoxins produced by common Aspergillus and Penicillium species. In young chickens fed aflatoxin at various doses, multiple clotting factors were suppressed. Prothrombin, a key protein in the clotting cascade, was the most sensitive, dropping at the lowest dose tested. Factors VII, V, and X all declined at higher doses, and fibrinogen was also reduced. The overall picture was severe impairment of the clotting pathway.10Toxicology and Applied Pharmacology. Impairment of coagulation function during aflatoxicosis in young chickens Ochratoxin A produced a similar but distinct pattern of coagulopathy in the same species, with fibrinogen being the most sensitive factor and prothrombin declining only at higher doses.11Toxicology and Applied Pharmacology. Severe coagulopathy in young chickens produced by ochratoxin A
These findings are from controlled feeding studies in poultry, not from human indoor exposure, and the doses involved are far higher than what a person would typically encounter in a moldy home. But they illustrate an important point: the assumption that “mold = clots” oversimplifies the biology. Mycotoxins can disrupt the clotting system in multiple ways, and in many cases the disruption leads to bleeding problems rather than excessive clotting. The liver produces most clotting factors, and mycotoxins like aflatoxin are potent liver toxins, which explains why clotting factor production drops.
That said, the vascular picture is not limited to clotting factor suppression. A review of mycotoxin effects on vascular and bone health highlighted that prolonged oxidative stress from mycotoxin exposure can damage endothelial cells, the cells lining blood vessels. This damage involves the scavenging of nitric oxide by reactive oxygen species, leading to endothelial dysfunction. When endothelial cells become activated and inflamed, they interact with leukocytes and platelets and express inflammatory cytokines, creating conditions that could theoretically promote localized clotting even while systemic clotting factors are depleted.12Frontiers in Nutrition. Metabolic Disruption by Naturally Occurring Mycotoxins in Circulation: A Focus on Vascular and Bone Homeostasis Dysfunction The net effect would depend on which mechanism dominates at a given exposure level, a question that remains largely unresolved in humans.
When Mold Treatment Itself Disrupts Clotting
There is another, often overlooked way that mold problems intersect with blood clot risk: the drugs used to treat fungal infections can dramatically alter clotting if you are on blood thinners. Azole antifungals, the workhorse class of drugs for everything from toenail fungus to invasive aspergillosis, interact strongly with warfarin, one of the most commonly prescribed anticoagulants.
The mechanism is straightforward. Warfarin is broken down in the liver by specific enzymes, and azole antifungals block those same enzymes. When both drugs are taken together, warfarin accumulates to dangerously high levels. In clinical analyses, patients taking fluconazole alongside warfarin saw their INR (a measure of how thin the blood is) roughly double, and patients on voriconazole saw increases of more than fourfold.13PubMed Central. Clinical analysis of the effects of azole antifungal agents on the anticoagulant activity of warfarin A separate study confirmed these patterns, finding that both fluconazole and voriconazole significantly increased warfarin’s anticoagulant activity, with the effect appearing within the first week of combined use.14PubMed. Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin
The practical consequence is a heightened risk of serious bleeding. Even reducing the fluconazole dose by half does not reliably prevent the interaction. Itraconazole, which works on a slightly different enzyme, was originally thought to have less effect, but clinical case reports have documented it amplifying warfarin’s action as well.15Journal of Skin and Sexually Transmitted Diseases. Drug interactions of azole antifungals If you are on warfarin or another blood thinner and develop a fungal infection requiring azole treatment, close monitoring of your clotting values is essential. This is not a niche concern: millions of people take warfarin, and fungal infections are common enough that the overlap is a routine clinical scenario.
The Gap Between Lab Findings and Household Mold Exposure
Most of the evidence described so far involves either active infections in immunocompromised patients or controlled laboratory studies with purified fungal components. What about the person living in an apartment with visible mold on the bathroom ceiling? Does that kind of chronic, low-level exposure raise blood clot risk?
The honest answer is that we do not have strong direct evidence for that scenario. The mechanisms that promote clotting in invasive aspergillosis require the fungus to actually grow inside your tissues and blood vessels, which is vanishingly rare in people with healthy immune systems. Inhaling mold spores from household sources is a fundamentally different kind of exposure. The spores may trigger allergic reactions, asthma, or respiratory irritation, but they are not invading your vasculature.
Mycotoxin exposure from indoor mold is a more plausible pathway to systemic effects, since mycotoxins can become airborne and be inhaled or ingested. But as the animal studies show, the dominant effect of the best-characterized mycotoxins on clotting is to impair it, not to promote it. And the doses used in those animal feeding studies far exceed what humans encounter indoors. There is biological plausibility for endothelial damage from chronic low-level mycotoxin exposure, but the leap from “endothelial damage in cell cultures” to “increased blood clot risk in someone living in a damp house” involves assumptions that have not been tested in controlled human studies.
This does not mean household mold exposure is harmless. The respiratory and allergic effects are well established, and chronic inflammation from any source is generally bad for cardiovascular health. But if you are specifically worried about blood clots because of mold in your home, the current evidence does not support that as a direct or primary concern for otherwise healthy people.
Fungal Enzymes That Actually Dissolve Clots
In one of those delightful complications that make biology messy, some mold species produce substances that break down blood clots rather than cause them. Researchers studying crude extracts from Aspergillus terreus found that the extract significantly prolonged clotting times in a dose-dependent manner. Prothrombin time values more than doubled at higher concentrations, and activated partial thromboplastin time climbed sharply as well. Even more striking, the extract achieved roughly 45% clot lysis in thrombolysis assays, a level not statistically different from streptokinase, a drug used clinically to dissolve clots in heart attack and stroke patients.16International Journal of Health & Business Analytics. In-Vitro Anticoagulant and Thrombolytic Properties of Crude Aspergillus terreus Extract
This is laboratory research, not a suggestion that mold exposure will protect you from clots. But it illustrates why blanket statements about mold and blood clots are misleading. Different mold species, different fungal molecules, and different exposure contexts push clotting in different directions. The same genus, Aspergillus, includes species whose infections promote fatal thrombosis and species whose extracts dissolve clots in a test tube. Biology rarely offers the clean narratives that headlines prefer.
Who Actually Needs to Worry
If you are immunocompromised from organ transplantation, chemotherapy, high-dose corticosteroids, or advanced HIV, invasive fungal infections are a genuine and recognized risk factor for thrombosis. The combination of direct vascular invasion, platelet activation by fungal products, and the chronic inflammatory state these infections create can meaningfully increase clot risk. Your medical team is already watching for this.
If you are on warfarin or similar anticoagulants and develop a fungal infection requiring azole treatment, the drug interaction is a practical and immediate concern that requires careful dose monitoring and frequent INR checks. Do not assume your clotting medication is working the same way once an antifungal enters the picture.
If you are an otherwise healthy person living or working in a moldy environment, your concerns are better directed toward respiratory health, allergy management, and remediation of the moisture source. The mechanistic pathways between mold exposure and clotting exist in laboratory models and in severely ill patients, but the bridge to everyday indoor mold exposure and thrombotic events in healthy individuals has not been built by the evidence we have so far. Persistent indoor mold still warrants action for plenty of well-established health reasons, but blood clots are not at the top of that list.